Impact of HER2 Overexpression and Coexpression of Hormonal Receptors on Pathological Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

被引：0
|
作者：
Moscoso, Louis [1 ]
Ruiz-Merino, Guadalupe
Huayna, Lourdes Salazar [1 ]
Iborra-Lacal, Emma
de Romani, Santiago Escriva [2 ]
Jimenez-Lucas, Maria
Raber, Christian Siso [1 ]
Cabezas-Herrera, Juan
Peg, Vicente [1 ]
Ramon Y Cajal, Santiago [3 ]
Pinero-Madrona, Antonio
机构：
[1] Hosp Univ Vall dHebron, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
152
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [41] HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
    Zhao, Jing
    Krishnamurti, Uma
    Zhang, Chao
    Meisel, Jane
    Wei, Zhimin
    Suo, Aili
    Aneja, Ritu
    Li, Zaibo
    Li, Xiaoxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [42] Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer
    van de Ven, S.
    Smit, V. T. H. B. M.
    Dekker, T. J. A.
    Nortier, J. W. R.
    Kroep, J. R.
    CANCER TREATMENT REVIEWS, 2011, 37 (06) : 422 - 430
  • [43] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    CANCER RESEARCH, 2021, 81 (04)
  • [44] Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    Altundag, Kadri
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (02) : 328 - 328
  • [45] Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
    Wang, Ruo-Xi
    Chen, Sheng
    Jin, Xi
    Chen, Can-Ming
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 259 - 267
  • [46] Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
    Ruo-Xi Wang
    Sheng Chen
    Xi Jin
    Can-Ming Chen
    Zhi-Ming Shao
    Breast Cancer Research and Treatment, 2017, 161 : 259 - 267
  • [47] Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Aidan C. Li
    Jing Zhao
    Chao Zhao
    Zhongliang Ma
    Ramon Hartage
    Yunxiang Zhang
    Xiaoxian Li
    Anil V. Parwani
    Breast Cancer Research and Treatment, 2020, 180 : 321 - 329
  • [48] Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Li, Aidan C.
    Zhao, Jing
    Zhao, Chao
    Ma, Zhongliang
    Hartage, Ramon
    Zhang, Yunxiang
    Li, Xiaoxian
    Parwani, Anil, V
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 321 - 329
  • [49] Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast
    Usui, Yuki
    Matsunuma, Ryoichi
    Yamaguchi, Kei
    Hayami, Ryosuke
    Muramatsu, Aya
    Suzuki, Makoto
    Tsuneizumi, Michiko
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1536 - 1541
  • [50] Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade
    Yoon, Ga Young
    Chae, Eun Young
    Cha, Joo Hee
    Shin, Hee Jung
    Choi, Woo Jung
    Kim, Hak Hee
    Kim, Jeong Eun
    Kim, Sung-Bae
    CLINICAL BREAST CANCER, 2020, 20 (01) : 25 - 32
12345